Q4 2025 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2026-02-17 · accession 0001420506-26-000497
$159.3M
Reported value
9
Positions
2025-12-31
Period end
The Brief · Blue Water Life Science Advisors, LP · Q4 2025
AI · grounded in 13F
Blue Water Life Science Advisors, LP initiated a new position in TWST valued at $12.1M. The fund also opened a new stake in GRAL worth $8.5M and increased its holding in QTRX by 118.4%. Conversely, the fund reduced its positions in ADPT by 17.7% and GH by 12.5%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131M109 | GH | GUARDANT HEALTH INC | $36.3M | 22.8% | 355,047 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $32.4M | 20.3% | 141,494 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $28.7M | 18.0% | 1,765,145 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $13.3M | 8.37% | 1,676,300 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $13.3M | 8.35% | 2,092,147 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $12.1M | 7.63% | 383,000 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $9.6M | 6.03% | 510,000 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $8.5M | 5.32% | 99,000 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $5.1M | 3.20% | 86,412 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.